` 7459 (Medipal Holdings Corp) vs 0HF3 (Amerisourcebergen Corp) Comparison - Alpha Spread

7459
vs
A
0HF3

Over the past 12 months, Medipal Holdings Corp has outperformed 0HF3, delivering a return of +18% compared to the 0HF3's +13% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
7459
0HF3
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Medipal Holdings Corp Intrinsic Value
LOCKED
Unlock
0HF3 Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Medipal Holdings Corp
TSE:7459
2 805.5 JPY
A
Amerisourcebergen Corp
LSE:0HF3
317.49 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
7459, 0HF3

7459
0HF3
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Medipal Holdings Corp
Revenue
A
Amerisourcebergen Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
7459, 0HF3

7459
0HF3
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Medipal Holdings Corp
TSE:7459
A
Amerisourcebergen Corp
LSE:0HF3
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Medipal Holdings Corp
6.9%
0HF3
3.6%

Operating Margin

Medipal Holdings Corp
1.4%
0HF3
1.2%

Net Margin

Medipal Holdings Corp
1.1%
0HF3
0.5%

FCF Margin

Medipal Holdings Corp
0.9%
0HF3
1.1%

ROE

Medipal Holdings Corp
6.5%
0HF3
152.3%

ROA

Medipal Holdings Corp
2.1%
0HF3
2.2%

ROIC

Medipal Holdings Corp
5.6%
0HF3
15.2%

ROCE

Medipal Holdings Corp
6.4%
0HF3
23.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
7459, 0HF3

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
7459, 0HF3

Performance Gap Between 7459 and 0HF3
LOCKED
Unlock

Performance By Year
7459, 0HF3

Loading
7459
0HF3
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 7459 to other stocks
MCK
Mckesson Corp
More expensive
vs Medipal Holdings Corp
COR
Cencora Inc
Cheaper
vs Medipal Holdings Corp
CAH
Cardinal Health Inc
More expensive
vs Medipal Holdings Corp
SIG
Sigma Healthcare Ltd
More expensive
vs Medipal Holdings Corp
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett